Osteoarthritis and Bone Disorders News

The American College of Rheumatology, in partnership with the Arthritis Foundation, has released an update to its Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee, for the first time adding provisions that include direct patient participation, according to a press release.

Results from a recently published study demonstrated overloading and underloading may lead to worsening cartilage damage in the medial tibiofemoral joint, and underloading may lead to worsening damage in lateral patellofemoral cartilage.

The rheumatology community lost clinician and educator Calvin R. Brown, MD, on Dec. 1, 2019. He was 66 years old. His final years were spent at the Northwestern University Feinberg School of Medicine, practicing rheumatology and training fellows in the specialty.

Although there are considerable intersectional inequalities among various age, gender and socioeconomic groups in the likelihood of diagnosis for osteoarthritis, gout and rheumatoid arthritis, no such inequalities were found for spondyloarthritis diagnosis, according to findings published in Arthritis Care & Research.

Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious adverse events in patients who were treated with unapproved stem cell products, particularly those marketed as containing exosomes.

When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the timely convergence of widely available MP3 player technology, inexpensive audio software and weblog culture — a renaissance of radio programs that could be downloaded and played at the listener’s convenience, anytime or anywhere.

ATLANTA — A 0.07 mg intra-articular injection of lorecivivint, a Wnt pathway inhibitor, was associated with improvements in patient-reported pain and function compared with placebo, according to findings presented in a poster at ACR/ARP 2019.

ATLANTA — Romosozumab increases bone mineral density among patients with osteoporosis across different levels of renal function, according to a presenter at ACR/ARP 2019.

ATLANTA — A vast majority of patients with a cross-section of rheumatic diseases reported that pain, fatigue and mental health issues were those they would like researchers to track, according to a speaker at ACR/ARP 2019.

ATLANTA — Among patients with osteoarthritis, opioids demonstrated only moderate benefit for pain and function, while contributing no notable benefit for quality of life or depression compared with placebo, according to a presentation at the 2019 ACR/ARP Annual Meeting.